Hospital das Clínicas de Ribeirão Preto
Hospital das Clínicas de Ribeirão Preto
Campus Universitário S/N, Bloco G Subsolo II, Monte Alegre, Ribeirão Preto, Sao Paulo
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Camila Donadel
Raphael Liberatore, Jr.
Ligia Moreira Freitas
Rogerio Serafim Parra
Irai S Oliveira
Sabrina Ando
Maristella dos Reis
Vanessa Foresto Leal Machado
Daniele Ribeiro Contin
Wilson Marques
Anna Lara Peres
Lilian Shizuka Sonobe
Beatriz Fernanda de Sousa
Raul Bertassi
Victoria dos Santos
Naiara Chinellato
Open studies
Lung cancer
Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer - Hospital das Clínicas de Ribeirão PretoSee more
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) - KANDLELIT-007 - Merck Sharp & Dohme LLCSee more
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer - DESTINY-Lung06 - Daiichi SankyoSee more
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Symbiotic-Lung-01 - PfizerSee more
Crohn's disease
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) - MK-7240-008 - Merck Sharp & Dohme LLCSee more
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) - MK-7240-008 - Merck Sharp & Dohme LLCSee more
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease - AMAY - Eli Lilly and CompanySee more
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease - TakedaSee more
Gastroesophageal cancer
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Daiichi SankyoSee more
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Daiichi SankyoSee more
Non-Hodgkin Lymphoma
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
Lupus
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis - SOLUNA - Hoffmann-La RocheSee more
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis - SOLUNA - Hoffmann-La RocheSee more
Prostate cancer
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) - MK-2400-01A/IDeate-Prostate02 - Merck Sharp & Dohme LLCSee more
Breast Cancer
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer - DESTINY-Breast15 - Daiichi SankyoSee more
Gastric cancer
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Daiichi SankyoSee more
Leukemia
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
Multiple myeloma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more
Hemophilia
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A - ZEBRHA 2 - Hoffmann-La RocheSee more
Sleep disorders
Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke - ATACS - Hospital das Clínicas de Ribeirão PretoSee more
Stroke
Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke - ATACS - Hospital das Clínicas de Ribeirão PretoSee more
